Neuraxis Inc. (NYSE AMERICAN: NRXS) Stock Information | RedChip

Neuraxis Inc. (NYSE AMERICAN: NRXS) Listen to this Section


$3.14
+0.0050 ( +0.16% ) 1.8K

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Market Data


Insider Ownership Transactions

Total Amount Purchased: -820,891.00 | $ -2,577,597.74

Date Type Amount Purchased Purchaser
2024-07-02 Sale -11580.00 Watkins Bradley Mitchell
2024-07-02 Sale -11580.00 Keyser Jane Elizabeth
2024-07-02 Sale -1183.00 Ferge Kristin A
2024-02-29 Sale -75000.00 Hannasch Brian
2024-02-14 Sale -150000.00 Hannasch Brian
2024-01-23 Sale -40000.00 Hannasch Brian
2023-08-10 Sale -531548.00 MASIMO CORP

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 70 Aug 09, 2024
8-k 8K-related 14 Aug 09, 2024
8-k 8K-related 14 Jul 05, 2024
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 02, 2024
def Proxies and info statements 6 Jul 01, 2024
ars Annual reports 1 Jul 01, 2024
pre Proxies and info statements 6 Jun 21, 2024
8-k 8K-related 16 May 28, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.